Australia markets closed

AirBoss of America Corp. (ABSSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
32.87-1.22 (-3.59%)
At close: 03:44PM EST
Full screen
Trade prices are not sourced from all markets
Previous close34.09
Bid0.00 x 0
Ask0.00 x 0
Day's range32.69 - 32.78
52-week range12.79 - 36.38
Avg. volume2,906
Market cap887.746M
Beta (5Y monthly)1.47
PE ratio (TTM)19.52
EPS (TTM)1.68
Earnings date07 Mar 2022 - 11 Mar 2022
Forward dividend & yield0.32 (0.97%)
Ex-dividend date30 Dec 2021
1y target estN/A
  • GlobeNewswire

    AirBoss Announces Updated Opportunity Pipeline and Revised Guidance

    NEWMARKET, Ontario, Dec. 28, 2021 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX: ABSSF) (the “Company” or “AirBoss”) announced today an update with respect to deliveries by AirBoss Defense Group (“ADG”) of nitrile patient examination gloves previously slated for the fourth quarter of 2021. This year has presented unprecedented challenges to ADG, with ongoing customs, logistics and border delays at the ports of Los Angeles and Long Beach, as well as the previously disclosed COVID

  • PR Newswire

    Small Cap Growth Investor Presentations Now Available for On-Demand Viewing

    Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the December 2nd Small Cap Growth Virtual Investor Conference are now available for on-demand viewing.

  • GlobeNewswire

    AirBoss Announces Intention to Renew Normal Course Issuer Bid

    NEWMARKET, Ontario, Dec. 02, 2021 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (the "Company") (TSX:BOS) announced today that the Toronto Stock Exchange ("TSX") has accepted its Notice of Intention to renew its normal course issuer bid for its common shares (the "Bid"). Purchases made pursuant to the Bid will be made in the open market through the facilities of the TSX and alternative Canadian trading systems, if eligible, in accordance with applicable regulatory requirements. For its current Bi